NCT04666129 2025-08-17Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerSumitomo Pharma America, Inc.Phase 1 Completed48 enrolled